新生儿糖尿病：诊断与管理的最新进展
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
作者信息
Lemelman Michelle Blanco, Letourneau Lisa, Greeley Siri Atma W
机构信息
Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, MC 5053, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Monogenic Diabetes Registry, University of Chicago Medicine, Kovler Diabetes Center, 900 East 57th Street, Chicago, IL 60637, USA.
出版信息
Clin Perinatol. 2018 Mar;45(1):41-59. doi: 10.1016/j.clp.2017.10.006. Epub 2017 Dec 16.
Abstract
Neonatal diabetes mellitus is likely to be due to an underlying monogenic defect when it occurs at less than 6 months of age. Early recognition and urgent genetic testing are important for predicting the clinical course and raising awareness of possible additional features. Early treatment of sulfonylurea-responsive types of neonatal diabetes may improve neurologic outcomes. It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infection, stress, inadequate pancreatic insulin production in preterm infants, among others. This review explores the diagnostic approach, mutation types, management, and clinical course of neonatal diabetes.
摘要
新生儿糖尿病若在6个月龄之前发病，很可能是由潜在的单基因缺陷所致。早期识别和紧急基因检测对于预测临床病程以及提高对可能存在的其他特征的认识非常重要。对磺脲类药物敏感型的新生儿糖尿病进行早期治疗可能会改善神经学预后。区分新生儿糖尿病与新生儿高血糖的其他病因很重要。其他病因包括感染、应激、早产儿胰腺胰岛素分泌不足等。本综述探讨了新生儿糖尿病的诊断方法、突变类型、管理及临床病程。
相似文献
1
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Clin Perinatol. 2018 Mar;45(1):41-59. doi: 10.1016/j.clp.2017.10.006. Epub 2017 Dec 16.
2
Remission of severe neonatal diabetes with very early sulfonylurea treatment.
Diabetes Care. 2015 Mar;38(3):e38-9. doi: 10.2337/dc14-2124.
3
Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
Front Endocrinol (Lausanne). 2023 May 11;14:1143736. doi: 10.3389/fendo.2023.1143736. eCollection 2023.
4
Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
J Pediatr Endocrinol Metab. 2017 May 1;30(5):593-596. doi: 10.1515/jpem-2016-0261.
5
[Neonatal diabetes mellitus].
Duodecim. 2011;127(6):534-41.
6
Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.
Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690.
7
[Neonatal diabetes mellitus: treatment with sulfonylurea in a preterm born infant].
Klin Padiatr. 2009 Mar-Apr;221(2):100. doi: 10.1055/s-0029-1202867. Epub 2009 Mar 4.
8
ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.
9
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
J Perinatol. 2012 Aug;32(8):645-7. doi: 10.1038/jp.2012.46.
10
Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.
Front Endocrinol (Lausanne). 2021 Sep 9;12:727083. doi: 10.3389/fendo.2021.727083. eCollection 2021.
引用本文的文献
1
De Novo KCNJ11 Mutation in an Infant With Neonatal Diabetes Mellitus Presenting as Diabetic Ketoacidosis: A Case Report and Literature Review.
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251368092. doi: 10.1177/23247096251368092. Epub 2025 Aug 21.
2
Prenatal pembrolizumab exposure as the potential link among recurrent necrotizing enterocolitis, neonatal diabetes mellitus and exocrine pancreatic insufficiency: a case report.
Ital J Pediatr. 2025 Jul 18;51(1):237. doi: 10.1186/s13052-025-02021-8.
3
Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion.
Cureus. 2025 May 6;17(5):e83555. doi: 10.7759/cureus.83555. eCollection 2025 May.
4
Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus.
Front Pediatr. 2025 Apr 16;13:1456818. doi: 10.3389/fped.2025.1456818. eCollection 2025.
5
Real world evidence of insulin and biosimilar insulin therapy-Opportunities to improve adherence, outcomes and cost-effectiveness.
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16386.
6
Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions.
Children (Basel). 2025 Feb 12;12(2):219. doi: 10.3390/children12020219.
7
Monogenic Familial Neonatal Diabetes in Preterm Infant With Gene Mutation: Transition to Oral Sulfonylurea Therapy.
J Pediatr Pharmacol Ther. 2025 Feb;30(1):129-132. doi: 10.5863/1551-6776-30.1.129. Epub 2025 Feb 10.
8
Genetic Structure of Hereditary Forms of Diabetes Mellitus in Russia.
Int J Mol Sci. 2025 Jan 16;26(2):740. doi: 10.3390/ijms26020740.
9
Evaluation of criterion-based audit in improving quality of neonatal birth asphyxia care at Balaka district hospital in Malawi.
Matern Health Neonatol Perinatol. 2024 Nov 4;10(1):21. doi: 10.1186/s40748-024-00191-7.
10
Successful Transition to Sulfonylurea for Relapsed Monogenic Diabetes Due to Rare 6q23.3 Duplication.
JCEM Case Rep. 2024 Oct 16;2(10):luae180. doi: 10.1210/jcemcr/luae180. eCollection 2024 Oct.
本文引用的文献
1
Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis.
Diabetes Care. 2017 Oct;40(10):e147-e148. doi: 10.2337/dc17-1145. Epub 2017 Aug 4.
2
ABM Clinical Protocol #27: Breastfeeding an Infant or Young Child with Insulin-Dependent Diabetes.
Breastfeed Med. 2017 Mar;12:72-76. doi: 10.1089/bfm.2017.29035.djm. Epub 2017 Jan 30.
3
ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes.
Pediatr Diabetes. 2017 Nov;18(7):518-523. doi: 10.1111/pedi.12428. Epub 2016 Aug 24.
4
Prematurity and Genetic Testing for Neonatal Diabetes.
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2015-3926. Epub 2016 Aug 18.
5
Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls.
Diabet Med. 2016 Oct;33(10):1380-6. doi: 10.1111/dme.13159. Epub 2016 Jun 22.
6
Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes.
Diabetes. 2016 Jul;65(7):2094-2099. doi: 10.2337/db15-1690. Epub 2016 Apr 5.
7
Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
Diabetologia. 2016 Jun;59(6):1162-6. doi: 10.1007/s00125-016-3921-8. Epub 2016 Mar 31.
8
Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach.
J Pediatr Endocrinol Metab. 2016 May 1;29(5):523-31. doi: 10.1515/jpem-2015-0341.
9
Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Diabetes Technol Ther. 2015 Dec;17(12):872-9. doi: 10.1089/dia.2015.0030. Epub 2015 Oct 28.
10
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Diabetes Care. 2015 Nov;38(11):2033-41. doi: 10.2337/dc15-0837. Epub 2015 Oct 5.
Zotero 插件